Accuracy of Point-of-Care Measurement With the RapidPoint 500 Blood Gas Analyser

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

51 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-05-31

Study Completion Date

2016-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

ICU patients are at high risk of ionic or metabolic disturbances during the course of their critical illness. Some of these disturbances might be life-threatening and require rapid response from physicians. Point-of-Care determination of electrolytes, glucose, hemoglobin and hematocrit ensures early detection (within 1 minute) of abnormal values and allows rapid and appropriate therapy. This technology has largely improved the quality of care in ICU. However, the accuracy of the measurement of those parameters had to be close enough to the reference method, usually perfomed in the central lab but time consuming. Recently, a novel generation of blood gas analyser has been released. Among them, the RapidPoint 500 is mounted with a 28-day cartridge which provides automatic calibrations and quality controls several times a day. Such a technology dramatically decreases the need for labs technical interventions. To date, there is no data reporting the accuracy of this device. Therefore, the investigators' aim is to compare the accuracy of the RapidPoint 500 with a reference measurement performed at the central laboratory (Beckman\&Coulter AU5800 for electrolytes and Beckman\&Coulter DXH for hemoglobin).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Fluid Responsiveness Prediction at the Bedside

NCT00721604

Hypotension Shock

COMPLETED

Prognostic Value of Lactates in ICU

NCT04792736

Mortality

COMPLETED

Validation of the Accuracy of a Novel POCT Dry Electrolyte Analysis System in the Acute Care Setting

NCT06726460

Electrolyte Disorder Arrhythmia Stroke

RECRUITING

Mini Bolus for Fluid Challenge Responsiveness in the Emergency Department

NCT05369559

Fluid Therapy

RECRUITING EARLY_PHASE1

The Use of LiDCOplus in Fluid Resuscitation Decision-Making

NCT03349749

Shock

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Critical Care Electrolytes Point-of-Care Systems

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Current stay in ICU
* Presence of an indwelling arterial catheter (radial or femoral)
* Prescription by physicians of a blood gas analysis and a laboratory analysis for the next morning